These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 26890477)

  • 1. Latent Tuberculosis Infection Test Agreement in the National Health and Nutrition Examination Survey.
    Ghassemieh BJ; Attia EF; Koelle DM; Mancuso JD; Narita M; Horne DJ
    Am J Respir Crit Care Med; 2016 Aug; 194(4):493-500. PubMed ID: 26890477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prevalence of Latent Tuberculosis Infection in the United States.
    Mancuso JD; Diffenderfer JM; Ghassemieh BJ; Horne DJ; Kao TC
    Am J Respir Crit Care Med; 2016 Aug; 194(4):501-9. PubMed ID: 26866439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium Tuberculosis Infection, Immigration Status, and Diagnostic Discordance: A Comparison of Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube Test Among Immigrants to the U.S.
    Wilson FA; Miller TL; Stimpson JP
    Public Health Rep; 2016; 131(2):303-10. PubMed ID: 26957665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of discordant tuberculin skin test and QuantiFERON®-TB Gold In-Tube results in various high-risk groups.
    Weinfurter P; Blumberg HM; Goldbaum G; Royce R; Pang J; Tapia J; Bethel J; Mazurek GH; Toney S; Albalak R;
    Int J Tuberc Lung Dis; 2011 Aug; 15(8):1056-61. PubMed ID: 21740668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden setting.
    Chandrasekaran P; Mave V; Thiruvengadam K; Gupte N; Shivakumar SVBY; Hanna LE; Kulkarni V; Kadam D; Dhanasekaran K; Paradkar M; Thomas B; Kohli R; Dolla C; Bharadwaj R; Sivaramakrishnan GN; Pradhan N; Gupte A; Murali L; Valvi C; Swaminathan S; Gupta A;
    PLoS One; 2018; 13(8):e0199360. PubMed ID: 30067752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordance between TST and QFT-TBGold Plus for Latent Tuberculosis Screening among Under-Five Children: An Interim Analysis.
    Surve S; Bhor V; Naukariya K; Begum S; Munne K; Tipre P; Sutar N; Jaiswal A; Bhonde G; Chauhan S; Shah I
    J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34904674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of latent tuberculosis infection among migrant farmworkers along the US-Mexico border.
    Oren E; Fiero MH; Barrett E; Anderson B; Nuῆez M; Gonzalez-Salazar F
    BMC Infect Dis; 2016 Nov; 16(1):630. PubMed ID: 27809805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three tests for latent tuberculosis infection in high-risk people in the USA: an observational cohort study.
    Ho CS; Feng PI; Narita M; Stout JE; Chen M; Pascopella L; Garfein R; Reves R; Katz DJ;
    Lancet Infect Dis; 2022 Jan; 22(1):85-96. PubMed ID: 34499863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of latent tuberculosis infection among health care workers working in Hajj pilgrimage area in Saudi Arabia, using interferon gamma release assay and tuberculin skin test.
    Bukhary ZA; Amer SM; Emara MM; Abdalla ME; Ali SA
    Ann Saudi Med; 2018; 38(2):90-96. PubMed ID: 29620541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of discordant latent tuberculosis infection test results amongst South African health care workers.
    Adams S; Ehrlich R; Baatjies R; Dendukuri N; Wang Z; Dheda K
    BMC Infect Dis; 2019 Feb; 19(1):131. PubMed ID: 30736743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the tuberculin skin test and the QuantiFERON-TB Gold test in detecting latent tuberculosis in health care workers in Iran.
    Mostafavi E; Nasehi M; Hashemi Shahraki A; Esmaeili S; Ghaderi E; Sharafi S; Doosti-Irani A
    Epidemiol Health; 2016; 38():e2016032. PubMed ID: 27457062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of interferon-γ release assay to two cut-off points of tuberculin skin test to detect latent Mycobacterium tuberculosis infection in primary health care workers.
    de Souza FM; do Prado TN; Pinheiro Jdos S; Peres RL; Lacerda TC; Loureiro RB; Carvalho JA; Fregona G; Dias ES; Cosme LB; Rodrigues RR; Riley LW; Maciel EL
    PLoS One; 2014; 9(8):e102773. PubMed ID: 25137040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concordance between the tuberculin skin test and interferon gamma release assay (IGRA) for diagnosing latent tuberculosis infection in patients with systemic lupus erythematosus and patient characteristics associated with an indeterminate IGRA.
    Cho H; Kim YW; Suh CH; Jung JY; Um YJ; Jung JH; Kim HA
    Lupus; 2016 Oct; 25(12):1341-8. PubMed ID: 26985011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of latent tuberculosis infection among pre-clinical and clinical medical students using QuantiFERON-TB gold plus and tuberculin skin test at a teaching hospital in Thailand: A cross-sectional study.
    Chumpa N; Kawkitinarong K; Wongpiyabovorn J; Paitoonpong L; Suwanpimolkul G
    J Infect Public Health; 2022 Apr; 15(4):400-405. PubMed ID: 35325687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
    Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
    Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of QuantiFERON(®)-TB Gold In-Tube in tuberculosis contact investigation: experience in a tuberculosis unit.
    Gonzślez-Moreno J; García-Gasalla M; Gállego-Lezaun C; Fernández-Baca V; Mir Viladrich I; Cifuentes-Luna C; Serrano Bujalance A; Salom Vallespir A; Payeras Cifre A
    Infect Dis (Lond); 2015 Apr; 47(4):244-51. PubMed ID: 25692351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of healthcare workers for latent tuberculosis infection in the low tuberculosis burden country: QuantiFERON-TB gold in tube test or tuberculin skin test?
    Keshavarz Valian S; Mahmoudi S; Pourakbari B; Abdolsalehi MR; Eshaghi H; Mamishi S
    Arch Environ Occup Health; 2019; 74(3):109-114. PubMed ID: 30516445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden country.
    Hung WT; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2015 Apr; 48(2):147-52. PubMed ID: 24071516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QuantiFERON-TB Gold In-Tube test for diagnosis of latent tuberculosis (TB) infection in solid organ transplant candidates: a single-center study in an area endemic for TB.
    Ahmadinejad Z; Azmoudeh Ardalan F; Razzaqi M; Davoudi S; Jafarian A
    Transpl Infect Dis; 2013 Feb; 15(1):90-5. PubMed ID: 23173720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.